<DOC>
	<DOCNO>NCT02053662</DOCNO>
	<brief_summary>To develop simple blood urine test would perform patient start treatment predict risk bladder cancer might come back . To develop test investigator plan analyze blood , urine cancer tissue bladder cancer patient follow closely treatment . This include look change protein gene might play role bladder cancer biology . The investigator compare information obtain study blood , urine cancer tissue patient cure whose cancer come back . The knowledge difference patient potentially use develop blood urine test tell u high risk bladder cancer come back .</brief_summary>
	<brief_title>Biomarker Identification Bladder Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>Adult patient â‰¥18 year old . Patients suspect , clinically diagnose , histologically diagnose bladder cancer . Patients undergo cystoscopy without cancer suspicion . Ability give inform consent . Patients receive concurrent therapy second malignancy . &lt; 18 year old . Inability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Bladder Cancer</keyword>
</DOC>